₦airaland Forum

Do gals fall inlove dis days, a boyfriend or manfriend is a new pos machine... the more our dollar falls, the less gals fall in love

Funny observation, I wud go with the idea that u just want to know so that u wud time wen to have sex again... probably wen not to use condom I guess...

I don get alert Godwin

Is anybody contesting it... y is he getting worked up.. He shud come and point out the changes dat can be done in Nigeria

Is anybody contesting it... y is he getting work up.. he shud come and point out the changes dat can be done in Nigeria

I wud go and read d bible, cos it says we shud forgive and forget.. so I wud forgive

Since u dnt trust him,den come and trust me atleast u did nt catch me cheating

Now that we have change, pls let the transformation team do their job

Someone shud just tell him to keep quiet

Who did dey help na

Retail pharmacy is usually the first job most young pharmacists will get once they get their license. However, retail pharmacy can lead you to poverty if you ignore these warnings. A lot of young pharmacists that want to work in retail pharmacy before establishing their own retail pharmacy have been asking for my advise and here is what I have to say on how you can avoid winning the POOREST RETAIL PHARMACY owner award five years after you open your own retail pharmacy.

1.  Avoid a poor ambience premises- A retail pharmacy that is always dirty and has poor ambience will build that character into you. Since most dirty and poor ambience retail pharmacy are owned by poor pharmacists you too will end up poor. So, no matter what you are offered to even work as a locum in a poor looking pharmacy, reject the offer.

2. Avoid retail pharmacy with uneducated Superintendent – A lot of superintendent pharmacists are very poor because they know nothing about how to run a business. They are total illiterate when it comes to business management. If you work under them, you will never see the need to study the business side of retail pharmacy and once you do not study the business side of retail pharmacy, poverty is a guaranteed part of your destiny

3. Avoid working with Patent blaming retail pharmacists – Once you go to work in any retail pharmacy and the owner or the people working there are complaining about the patent medicine dealers around them, that is an alarm bell warning you never to get within 500 metres of that retail pharmacy again. Only poor and lazy pharmacists complain about patent medicine dealers. The hard working ones drive the patent medicine dealers around them out of business. As a young pharmacist, you do not want to start by working under a poor and lazy pharmacist who is using another person as the excuse for their laziness.

4. Avoid a pharmacy where the MD rarely attends any seminar or training- You became a pharmacists by attending pharmacy training in pharmacy school. You do not want to remain a pharmacist. You want to add RICH or SUCCESSFUL to your pharmacist title and to do that, you need training from the person you work under on success and wealth. Since the retail pharmacy owner that does not attend trainings cannot be wealthy, it means he or she can only teach you how to be poor because you can give only what you have and for that retail pharmacy owner that does not attend trainings on business management, what he or she will know is how to create poverty and they will readily teach you how to do that when you work under them.

5. Avoid retail pharmacy that do not make at least N100,000 sales per day in sales – Most of the retail pharmacy that are successful make daily sales of at least N100,000 per day. You can only become a millionaire when you deal on millions. N100000 per day is the minimum you must make to become qualified to be rich. If you meet any pharmacist that thinks this amount is too big and ridiculous, run away from that retail pharmacy because the owner is soaked in poverty mentality and can only transfer that mentality to you. However, if you meet a YOUNG PHARMACIST that owns a retail pharmacy that is less than 2 years and he or she tell you that they are doing under N100,000 but you can sense the desire and passion to break the N100,000 mark, work under that person for some time

6. AVOID THE COMMUNITY OF POOR RETAIL PHARMACY OWNERS – Look at the circle of retail pharmacy owning friends that you have and if their discussion is not made up of mostly how to improve their business, know that they are a community of Poverty afflicted retail pharmacy owners. Even if some of them seen to be doing well, avoid them. You learn what you practice from your friends and if the things you hear from your friends do not challenge you to want to become rich as a retail pharmacy owner, they are just programming you for poverty.

Am back, does anyone have a good gist for me

[quote][/quote]nice one...

It was in final year clinical class and Prof. Mrs. C.V Ukwe was taking us on hypertension. She concluded by saying we should look into JNC 7 report and its recommendations. I actually thought she had said GNC 7 but was proved wrong when I typed into Google search and what popped out was “search results for JNC 7”. Going through it, I was excited about this guideline as it improved my knowledge base and was hoping JNC 8 would be released soon as the amiable professor had said it was about time. This was in 2011.
For those still at sea, JNC 7 simply refers to the report of the 7th joint national committee on the prevention, detection, evaluation and treatment of high blood pressure. This means that there have been previous ones, that is, JNC 1-6. Experts are nominated to a panel to brainstorm on meta-analyses of clinical researches and studies carried out within a time frame, review previous guidelines and make recommendations. The JNC 7 was published in 2003 and so all expected that by 2010, JNC 8 should be out. It was not to be and it was not long before people started referring to the yet to be published guideline as “JNC late”. However, Dr. Smith who was a member of the JNC 8 expert panel explained that the delay was due to unprecedented prerelease review by numerous government agencies.
When finally it was published online on December 18, 2013, it didn’t meet a soft landing. The fact that it was not endorsed by the National Heart Blood Lung Institute(NHBLI), the American Heart Association and other health authorities was a real cause for concern. Infact, AHA stated that it still stands on the recommendations of JNC 7 and a new guideline should be expected in 2015 from them. The crux of the matter is that the JNC 8 committee declined to partner with AHA ab initio and AHA has some undisclosed reservations about the report. We leave them to settle their matter. More worrisome was a post by Dr. David K. Cundiff titled “A call to retract JNC 8 hypertension guideline” and the comments that followed on Kevinmd.com. He had co-authored a systematic review in the Cochrane Database of Systematic Reviews that found no evidence supporting drug treatment for patients of any age with mild hypertension ( SBP 140-159; DBP 90-99) with no previous cardiovascular disease, diabetes or renal disease. Comments that trailed the post instigated that drug companies might be up to making profits again alleging that the panel members’ financial obligation to drug companies had compromised the review by still leaving general target bp at below 140/90 and above which drug therapy should be instituted.
If you are a lippincott student, you may want to see a truth in this. Chapter 8 as written by Janet Fleetwood dwelt on contemporary bioethical issues in pharmacology and pharmaceutical research. In it we were made to understand that “the pharmaceutical industry combines a desire for discovery and development with profit-motivated marketing and sales goals. Although scientists and physicians share the desire for drug discovery and development and are motivated by the desire to contribute to scientific advancement and improved patient care, pharmaceutical companies are simultaneously under strong commercial pressures. Pharmaceutical companies are therefore willing to offer financial incentives to physician–researchers who conduct studies, recruit patients, or are helpful in product development and testing. In some cases, this financial support may compromise professional judgment in conducting, analyzing, or reporting researches.”2 Fleetwood went on to educate us that “the principle of nonmaleficence asserts that professionals have an obligation to prevent harm or if harm is unavoidable, minimize that harm. This principle plays an important role in clinical research, as it entails an obligation to minimize risks to each participant”.2 In this context, if I were to belong to David’s school of thought, the harm is that patients with BP range of 140/90-159/99 are made to take antihypertensive drugs when lifestyle modification can suffice predisposing them to the adverse effect of these drugs unnecessarily.
Though I may not be knowledgeable about the goings on in the American healthcare system, my candid opinion is that the allegation by Dr. David was unfounded. His research was one out of many that had to be reviewed and probably the only one supporting higher threshold for initiation of therapy. It was enough that they increased the Bp target and initiation of therapy for patients older than 60yrs to ‹150/90 and that for diabetics and CKD pts to ‹140/90 as research showed no additional benefit with lower BP targets. For the AHA to stick with JNC 7 having lower targets, it means probably that that study bore no weight. Let’s be honest with ourselves, even at the prehypertensive stage of 121-139 SBP, how many patients can boast of bringing down their Bp with exercise and DASH diet? Just how many have that discipline? Most actually end up being hypertensive and needing drugs. Despite the drug therapy, lifestyle modifications are still advised. Besides, the “Panel members disclosed any potential conflicts of interest including studies evaluated in the report and relationships with industry. Those with conflicts were allowed to participate in discussions as long as they declared their relationships, but they recused themselves from voting on evidence statements and recommendations relevant to their relationships or conflicts. Four panel members (24%) had relationships with industry or potential conflicts to disclose at the outset of the process. In January 2013, the guideline was submitted for external peer review by NHLBI to 20 reviewers, all of whom had expertise in hypertension, and to 16 federal agencies. Reviewers also had expertise in cardiology, nephrology, primary care, pharmacology, research (including clinical trials), biostatistics, and other important related fields. Sixteen individual reviewers and 5 federal agencies responded. Reviewers’ comments were collected, collated, and anonymized. Comments were reviewed and discussed by the panel from March through June 2013 and incorporated into a revised document”.1 Despite all these, the recommendations came with a caveat that although “this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient”.1 So, Dr. David is free to base his clinical judgement on his own study.
Among the panelists for the JNC 8 was a medical practitioner by name Olugbenga Ogedegbe, a Nigerian-American. We are proud of you and Barry L. Carter, PharmD., the pharmacist in the team. While health workers in this country are busy wasting their talents on salary and allowance squabbles, others are seeing to the good of their patients and actually having contentions over their patients’ welfare. Not even the health minister could give a public statement on what should be our stand on the JNC 8 report or do we need a surgeon general to do that? Better still, are we not supposed to generate our own research questions, set up our panelists and make recommendations based on indigenous clinical trials? We can’t continue to rely on JNC reports which are largely American to solve hypertension issues in Nigeria. The British have theirs and even in the same America many other guidelines coexist with the JNC making one have plethora of options to choose from.

I knew there wud be things like that but not to worry, its all politics

Ragner:
What's the 'hating' ?? Grow up Bro

Who is hating, are u okay, guy did u take something, quit it, cos its nt good for u

Come have u eaten today.. and u are here hating a small boy making money...

Anything wen kwakwaso dey talk na God win

My advice does nt count,what counts is my prayers

My dear,marriage is for better for worse, wat ever happens in marriage is till death.. let us have that mentality so that we wud be very careful as we choose our life partners. Divorce to me is only permited in the grounds of infidelity.. happiness or no happiness, choose wisely before saying I do

Who cares abt handshake, she shud keep her ebola striken hands to her self

I tot d president said he has nothing to do with d election, so y are dey saying he called a meeting, politics is so unpredictable

D last phase of ur story has answered ur question,so I wud advise u. Do the right thing

Buhari wud do wat ever he feels like doing,he now wears d cap and he knows where it itches most

So dis is ur focus, d number of times couples have sex in a year... my dear u need to look for aboda job.. pple are thinking of innovative ideas to move the country forward and how to make money u are calculating d numbet of times u shud have sex with ur wife.. guy u need to be kidnap

Gej actually saved Nigeria from blood shed by willingly conceding to the result of the election, but I choose to see dat action this way - maybe he is tired of goverment and their politics.. dont forget! dat man has been in Goverment for the past 16 years, he nees to rest

Why is buhari been too slow in thinking

I have heard, d next pls

Dats cool

Ask patience jonathan maybe she wud be able to profer a solution

Emdee590:
Or better still , let him go for loratidine , yeast and white vitamin c .

@ doc in the house , I wrong abi I right ?

That also correct no arguement abt dat